Analysis of the immune-status of patients with lymphoma

Analysis of the immune-status of patients with lymphoma - Immulymph

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00010064

Enrollment

200

Registered

2016-02-16

Start date

2016-02-16

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphoma Probandes without lymphoma

Interventions

Group 1: The project aims at investigating the immune status of patients with lymphoma in the peripheral blood, on tumor samples or apharesis products.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with Lymphoma 2. Probands without lymphoma 3. Age of consent

Exclusion criteria

Exclusion criteria: Portends who are not able to consent.

Design outcomes

Primary

Measure	Time frame
Basic research project: -Sterility of samples - FACS analysis of cellular composition	—

Secondary

Measure	Time frame
Basic research project: - Ability for expansion of T cells - Ability for transduction with chimeric antigene of T T cells	—

Countries

Germany

Contacts

Public ContactNatali Pflug

Uniklinik Köln

Natali.Pflug@uk-koeln.de0221-478-0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026